Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Acute effects of the glucagon-like peptide 2 analogue, teduglutide, on intestinal adaptation in short bowel syndrome

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Serum Calprotectin in Adolescents with Inflammatory Bowel Disease - A Pilot Investigation

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Bovine Colostrum For Preterm Infants in the First Days of Life: A Randomized Controlled Pilot Trial

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. F-calprotectin and blood markers correlate to Quality of Life in Pediatric Inflammatory Bowel Disease

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Surgical Management of Crohn Disease in Children - Guidelines from the Paediatric IBD Porto Group of ESPGHAN

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. The effect of glucagon-like peptide-1 and glucagon-like peptide-2 on microcirculation: a systematic review

    Research output: Contribution to journalReviewResearchpeer-review

  2. Novel GLP-1/GLP-2 co-agonists display marked effects on gut volume and improves glycemic control in mice

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Randomised clinical trial: 2% taurolidine versus 0.9% saline locking in patients on home parenteral nutrition

    Research output: Contribution to journalJournal articleResearchpeer-review

  • Thomas Thymann
  • Barbara Stoll
  • Lars Mecklenburg
  • Douglas G Burrin
  • Andreas Vegge
  • Niels Qvist
  • Thomas Eriksen
  • Palle B Jeppesen
  • Per T Sangild
View graph of relations

Neonatal short bowel syndrome following massive gut resection is associated with malabsorption of nutrients. The intestinotrophic factor glucagon-like peptide 2 (GLP-2) improves gut function in adult patients with short bowel syndrome, but its effect in pediatric patients remains unknown. Our objective was to test the efficacy of the long-acting synthetic human GLP-2 analogue, teduglutide (ALX-0600), in a neonatal piglet jejunostomy model. Two-day-old pigs were subjected to resection of 50% of the small intestine (distal part), and the remnant intestine was exteriorized on the abdominal wall as a jejunostomy. All pigs were given total parenteral nutrition for 7 days and a single daily injection of the following doses of teduglutide: 0.01 (n = 6), 0.02 (n = 6), 0.1 (n = 5), or 0.2 mg · kg · day (n = 6), and compared with placebo (n = 9). Body weight increment was similar for all 4 teduglutide groups but higher than placebo (P < 0.05). There was a dose-dependent increase in weight per length of the remnant intestine (P < 0.01) and fractional protein synthesis rate in the intestine was increased in the 0.2 mg · kg · day group versus placebo (P < 0.001); however, functional and structural endpoints including activity of digestive enzymes, absorption of enteral nutrients, and immunohistochemistry (Ki67, villin, FABP2, ChgA, and GLP-2R) were not affected by the treatment. Teduglutide induces trophicity on the remnant intestine but has limited acute effects on functional endpoints. Significant effects of teduglutide on gut function may require a longer adaptation period and/or a more frequent administration of the peptide. In perspective, GLP-2 or its analogues may be relevant to improve intestinal adaptation in pediatric patients with short bowel syndrome.

Original languageEnglish
JournalJournal of Pediatric Gastroenterology and Nutrition
Volume58
Issue number6
Pages (from-to)694-702
Number of pages9
ISSN0277-2116
DOIs
Publication statusPublished - Jun 2014

ID: 45056521